Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Ispire Technology
ISPR
$80.4M
| $53.4K | ﹤0.01% |
6,679
-5,744
| -46% | -$37K |
|
4027
Virginia National Bankshares
VABK
$258M
| $53.4K | ﹤0.01% |
1,627
-1,671
| -51% | -$48.7K |
|
4028
Outdoor Holding Co
POWW
$250M
| $53.4K | ﹤0.01% |
31,756
-31,666
| -50% | -$76.2K |
|
4029
ProKidney
PROK
$314M
| $53.3K | ﹤0.01% |
21,654
-9,943
| -31% | -$26.7K |
|
4030
Rigetti Computing
RGTI
$5.38B
| $53K | ﹤0.01% |
+49,516
| New | +$57.2K |
|
|
ONIT
4031
Onity Group
ONIT
$318M
| $52.8K | ﹤0.01% |
2,202
-2,351
| -52% | -$58K |
|
4032
Personalis
PSNL
$1.42B
| $52.7K | ﹤0.01% |
45,024
| – | – |
|
4033
Civeo
CVEO
$341M
| $52.6K | ﹤0.01% |
2,109
-88
| -4% | -$2.19K |
|
|
AOMR
4034
Angel Oak Mortgage REIT
AOMR
$222M
| $52.5K | ﹤0.01% |
4,009
-4,186
| -51% | -$48.8K |
|
|
GTHX
4035
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $52.5K | ﹤0.01% |
23,032
+16,730
| +265% | +$63.9K |
|
4036
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
| $52.5K | ﹤0.01% |
606
| – | – |
|
4037
Shattuck Labs
STTK
$679M
| $52.5K | ﹤0.01% |
13,594
+13,402
| +6,980% | +$109K |
|
4038
Atossa Therapeutics
ATOS
$21.6M
| $52.4K | ﹤0.01% |
+2,936
| New | +$65K |
|
4039
Nuvectis Pharma
NVCT
$696M
| $52.3K | ﹤0.01% |
8,270
-2,023
| -20% | -$13.8K |
|
4040
Arq
ARQ
$86.3M
| $52.3K | ﹤0.01% |
+8,619
| New | +$59.4K |
|
4041
BigBear.ai
BBAI
$1.38B
| $52.2K | ﹤0.01% |
34,552
-1,577
| -4% | -$2.46K |
|
4042
Tootsie Roll Industries
TR
$2.95B
| $52K | ﹤0.01% |
1,805
-1,611
| -47% | -$45.4K |
|
|
FSP
4043
Franklin Street Properties
FSP
$48.3M
| $52K | ﹤0.01% |
33,984
-68,723
| -67% | -$129K |
|
4044
Acumen Pharmaceuticals
ABOS
$157M
| $51.9K | ﹤0.01% |
21,446
-25,864
| -55% | -$82.3K |
|
|
FFNW
4045
DELISTED
First Financial Northwest, Inc
FFNW
| $51.8K | ﹤0.01% |
+2,451
| New | +$50.9K |
|
4046
Escalade
ESCA
$289M
| $51.8K | ﹤0.01% |
3,753
-3,404
| -48% | -$45.6K |
|
4047
LiveWire
LVWR
$356M
| $51.6K | ﹤0.01% |
6,736
-7,185
| -52% | -$50.2K |
|
4048
Cibus
CBUS
$145M
| $51.6K | ﹤0.01% |
5,235
-12,765
| -71% | -$193K |
|
4049
Cerence
CRNC
$404M
| $51.3K | ﹤0.01% |
18,129
-31,168
| -63% | -$222K |
|
4050
Lineage Cell Therapeutics
LCTX
$277M
| $51.2K | ﹤0.01% |
51,376
-42,551
| -45% | -$47K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.